-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - primary outcomes
3
Description of secondary outcome
Analysis Description of the pre-specified … or the year of study completion. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms
associated with anticoagulant use in the … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, study design, number of study part... … To describe eligible systematic reviews, a single team member will prepare a summary including the author
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/management-vestibular-schwannomas
June 11, 2021 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description … Topic Suggestion Description
Date submitted: June 11, 2021
Management of Vestibular
-
effectivehealthcare.ahrq.gov/products/diabetes-glucose-control/research
August 04, 2010 - Author Affiliations
Jodi B. Segal, M.D., M.P.H. a
Sydney M. Dy, M.D. b
E. … Results
Description of the Cohort
We received data on 1,234,540 individuals meeting the broad … Description of Individuals Using Exenatide by Treatment Period
In Table 1 is a description of the … Description of individuals with diabetes mellitus by date of first exenatide use
Covariates
First … Description of individuals with diabetes mellitus stratified by injectable medication use
Covariates
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Was there a clear description of the techniques used to identify the events?
5. … Was the description of the population adequate?
2. … Trials of rofecoxib vs NSAIDs
Author
year
Aspirin
permitted? … Trials of etoricoxib and lumiracoxib (Safety only)
Author
Year
Patient
masked? … Topical NSAIDs trials
External Validity
Author
Year
Patient
masked?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - ...........................................................................................7
Author … Results
Description of the Cohort
We received data on 1,234,540 individuals meeting the broad criteria … Description of Individuals Using Exenatide by Treatment Period
In Table 1 is a description of the patients … Description of individuals with diabetes mellitus stratified by injectable medication use
Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use (continued)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-models-care-draft-report-appendixes.pdf
August 18, 2023 - , Year Model Description/name
Model Location and
Organization
Country
Setting Population Served … , Year Model Description/name
Model Location and
Organization
Country
Setting Population Served … , Year Model Description/name
Model Location and
Organization
Country
Setting Population Served … , Year Model Description/name
Model Location and
Organization
Country
Setting Population Served … , Year Model Description/name
Model Location and
Organization
Country
Setting Population Served
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - Evidence Table
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population Baseline … on a
protein-restricted diet and the
rest were on BH4.
97.7% of the early diagnosed
Study Description … Analysis of lifetime Phe data
showed that Phe levels at
ages 4, 5, and 6 accounted for
Study Description … within therapeutic targets and
a decrease in the values above
target…, and decreased the
Study Description … No studies identified
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - Timing Original studies published from
2019 onwards, the year of the
search done for the MHS III report … reviewed by a single team member to confirm eligibility and prepare a summary of the study,
including author … , year, study design, number of study participants, and main findings relevant to
the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including
the author … , year, number of studies by study design, and main findings relevant to each of our
review questions
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
October 29, 2021 - high-utilizers-health-care/research
Published Online: October 29, 2021
2
Summary of Peer Reviewer Comments and Author … Changes included improving the description of the
inclusion/exclusion criteria in methods; more clearly … We
expanded our description of the realist review literature rigor assessment to better
explain how … high-utilizers-health-care/research
Published Online: October 29, 2021
5
Public Comments and Author … stakeholder interpretation of LCA and
k-means outputs, and demonstrates significant differences in 1-year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
October 01, 2012 - Did the authors provide a detailed description of the
alternatives?
a. … Source and description of cost valuation
17. … Description of comparator programs
6. Boundaries of the analysis
7. Time horizon
8. … Description of model used
12. Modeling assumptions
13. Diagram of event pathway
14. … Did the author(s) explicitly discuss direction and magnitude of potential biases?
15.
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - Comment Response
Peer Reviewer
#1
Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description
of the findings to the beginning of the result … We have included a
description of and a citation for the DECIDE study in the
“Future Areas for Research … Peer Reviewer
#2
Background The Background was thorough in its description of the clinical
problem … Peer Reviewer
#4
Methods “Systematic review” may not be the most appropriate description of
this
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - • No outcome of interest
Timing Original studies published from
2011 onwards, the year of the … reviewed by a single team member to confirm eligibility and prepare a summary of
the study, including author … , year, study design, number of study participants, and main
findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, number of studies by study design, and main findings
relevant to each of our review questions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
September 01, 2020 - This report is made available to the public under the terms of a licensing agreement between the
author … Implementation
Strategies
No description No description No description No description No description … No description No description No description
28. … Organizational
History of
Change
No description No description No description No description No description … Fidelity
No description No description No description No description No description No description
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-insurance-prior-authorizations.pdf
December 03, 2020 - 2017. doi:
https://www.cdc.gov/nchs/data/nsltcp/2016_NSLTCP_RCC_Weighted_Estimates.pdf.
4
Author … The findings and conclusions in this document are those of
the author(s) who are responsible for its … See Appendix B for detailed description of
the criteria. … References
Author
Impact of a New Evidence Review
Yes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
August 04, 2023 - In the United States,
more than 2.8 million antimicrobial-resistant infections occur each year and … Usual practice or other type of
PSP
• No concurrent or historical
comparison group
• No clear description … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … reviewed by a single team member to confirm eligibility and prepare a summary of the study,
including author … To describe eligible systematic reviews, a single team member will prepare a summary including
the author
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Patient populations (continued)
Author, Year
Country,
Study Design
Inclusion Criteria Exclusion … Patient populations (continued)
Author, Year
Country,
Study Design
Inclusion Criteria Exclusion … Patient populations (continued)
Author, Year
Country,
Study Design
Inclusion Criteria Exclusion … Patient populations (continued)
Author, Year
Country,
Study Design
Inclusion Criteria Exclusion … Vibration interventions II
Author, Year
Type of
Footwear
Worn on
Platform
Support
Device
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
September 01, 2011 - However, a
description of meta-analysis goes beyond
this report. … The description of industry funding has been
removed. … The description of industry funding has been
removed. … (Lovell, Reiff,
Jones, et al., 2006) or 8-year (Lovell, Reiff, Ilowite, et al., 2008 follow-
up. … However, the description of
methotrexate has been expanded.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
November 21, 2012 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description … Topic Suggestion Description
Date submitted: November 21, 2012
Download Topic Suggestion … of PPACA) gives CMS the authority to expand the gainsharing bonus program nationwide after the first year … Nominator Information
Other Information About You: (optional)
Please choose a description that … of PPACA) gives CMS the authority to expand the gainsharing bonus program nationwide after the first year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-draft-appendixes.pdf
January 01, 2024 - C-5
Author, year Goal Review Limitations* Summarized
Evidence
Main Findings
Vaartio-Rajalin, … C-8
Author, year Goal Review Limitations* Summarized
Evidence
Main Findings
Jutkowitz,
201616 … C-10
Author, year Goal Review Limitations* Summarized
Evidence
Main Findings
Oeseburg,
200925 … Characteristics of included primary studies: Randomized controlled trials
Author, Year; Length of … Usual
Care: OR: 1.37 (95% CI: 0.72, 6.16)
D-6
Author, Year; Length of
Followup
Population